Markers of sensitivity or resistance to tyrosine kinase inhibitors (TKIs) in NSCLC patients harboring wild type EGFR.
Paola Ulivi
No relevant relationships to disclose
Elisa Chiadini
No relevant relationships to disclose
Alessandra Dubini
No relevant relationships to disclose
Maurizio Puccetti
No relevant relationships to disclose
Marco Angelo Burgio
No relevant relationships to disclose
Angelo Delmonte
No relevant relationships to disclose
Alberto Verlicchi
No relevant relationships to disclose
Alessandro Gamboni
No relevant relationships to disclose
Maximilian Papi
No relevant relationships to disclose
Giovenzio Genestreti
No relevant relationships to disclose
Wainer Zoli
No relevant relationships to disclose
Lucio Crino
No relevant relationships to disclose
Claudio Dazzi
No relevant relationships to disclose